Amato Giaccia

Postdoctoral Advisees

Laura Castellini , Chieh-Fang Cheng , Elizabeth Finger , Adam Krieg , Edwin Lai , Erinn Rankin , Olga Razorenova

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

Research in my lab focuses on the cellular response to stresses found in the tumor microenvironment, especially low oxygen conditions (tumor hypoxia). Our long-term goal is to identify and characterize the molecular and physiological changes induced by the tumor microenvironment that influence the malignant progression of transformed cells. Thus, by understanding the molecular changes which are important for tumor cells to survive in nutrient and oxygen depleted conditions, potentially new targets for cancer therapy will be identified. For the last few years, we have been studying three phenotypes of cells invoked under hypoxic conditions: 1) cessation of cell proliferation under low oxygen conditions, 2) cell death induced by low oxygen conditions, and 3) the angiogenic switch of dormant tumors to rapidly expanding tumors. Let me briefly discuss each of these projects and their potential clinical significance.1) Hypoxia induces a G1/early S-phase cell-cycle arrest. This arrest is different from the cell-cycle arrest induced by gentoxic stress, but may share some of the same genetic determinants such as the retinoblastoma (Rb) tumor suppressor gene. Phosphorylation of Rb is essential for G1 to S-phase progression in the cell-cycle and is controlled by cyclin-cdk activity. Cyclin-cdk activity is controlled by a group of small molecular weight inhibitors which bind to these complexes and inhibit their kinase activity. At present, our data suggest that two of these inhibitors, p21 and p27, are essential in controlling hypoxia/reoxygenation induced cell-cycle arrest. We are continuing to use a combination of genetic and biochemical approaches to examine the state of this pathway in transformed tumor cells to determine whether loss of this checkpoint plays any role in genomic instability. In addition, we are also investigating the complexity of this arrest to determine whether other pathways also contribute to this arrest at different oxygen tensions.2) Hypoxia is a potent...

Publications

• ATM activation and signaling under hypoxic conditions. Bencokova Z, Kaufmann MR, Pires IM, Lecane PS, Giaccia AJ, Hammond EM. Mol Cell Biol. 2009; 29 (2): 526-37
• Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ. Cancer Cell. 2009; 15 (1): 35-44
• The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, Kambham N, Feazell J, Yang GP, Koong A, Giaccia AJ. Cancer Res. 2009; 69 (3): 775-84
• Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Chan DA, Kawahara TL, Sutphin PD, Chang HY, Chi JT, Giaccia AJ. Cancer Cell. 2009; 15 (6): 527-38
• Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. Le QT, Harris J, Magliocco AM, Kong CS, Diaz R, Shin B, Cao H, Trotti A, Erler JT, Chung CH, Dicker A, Pajak TF, Giaccia AJ, Ang KK. J Clin Oncol. 2009; 27 (26): 4281-6